Published in Br J Rheumatol on June 01, 1987
Abrogation of macrophage-dependent injury in experimental glomerulonephritis in the rabbit. Use of an antimacrophage serum. J Clin Invest (1981) 2.41
Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum (1999) 2.17
Prominence of cell-mediated immunity effectors in "pauci-immune" glomerulonephritis. J Am Soc Nephrol (1999) 2.11
Tissue culture of isolated glomeruli in experimental crescentic glomerulonephritis. J Exp Med (1978) 2.02
The macrophagen in human rapidly progressive glomerulonephritis. Lancet (1976) 1.88
Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. Kidney Int (1997) 1.66
More emphasis on the enthesis. J Rheumatol (1989) 1.64
Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Int (1999) 1.55
Tumor necrosis factor production by glomerular macrophages in anti-glomerular basement membrane glomerulonephritis in rabbits. Lab Invest (1991) 1.49
Role of CFTR mutations in adult bronchiectasis. Thorax (2004) 1.46
Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med (2000) 1.44
A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease. J Rheumatol (1988) 1.43
Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum (1998) 1.39
Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med (1997) 1.38
Fibrositis/fibromyalgia syndrome: the key to the puzzle of chronic pain. Med J Aust (1990) 1.38
A glossary of pain terms for medicolegal work. Med J Aust (1991) 1.38
T lymphocyte participation in antibody-induced experimental glomerulonephritis. Kidney Int (1985) 1.36
Antibody independent crescentic glomerulonephritis in mu chain deficient mice. Kidney Int (1997) 1.35
Participation of cell-mediated immunity in deposition of fibrin in glomerulonephritis. Lancet (1988) 1.32
Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit. J Clin Invest (1985) 1.31
The macrophage in the development of experimental crescentic glomerulonephritis. Studies using tissue culture and electron microscopy. Am J Pathol (1979) 1.31
The effect of defibrination on macrophage participation in rabbit nephrotoxic nephritis: studies using glomerular culture and electronmicroscopy. Clin Exp Immunol (1979) 1.28
IFN-gamma mediates crescent formation and cell-mediated immune injury in murine glomerulonephritis. J Am Soc Nephrol (1999) 1.27
Fibromyalgia syndrome: assessment of the severity of the condition 2 years after diagnosis. J Rheumatol (1994) 1.26
Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. Blood (1999) 1.25
Mechanisms of T cell-induced glomerular injury in anti-glomerular basement membrane (GBM) glomerulonephritis in rats. Clin Exp Immunol (1997) 1.25
Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis. Eur J Immunol (1997) 1.23
Evidence for delayed-type hypersensitivity mechanisms in glomerular crescent formation. Kidney Int (1994) 1.23
P-selectin directs T lymphocyte-mediated injury in delayed-type hypersensitivity responses: studies in glomerulonephritis and cutaneous delayed-type hypersensitivity. Eur J Immunol (1996) 1.19
Crescentic glomerulonephritis is diminished in fibrinogen-deficient mice. Am J Physiol Renal Physiol (2001) 1.19
A role for P selectin in complement-independent neutrophil-mediated glomerular injury. Kidney Int (1994) 1.16
TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy. J Autoimmun (2010) 1.16
Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis. Kidney Int (2000) 1.15
Tissue culture of isolated human glomeruli. Pathology (1978) 1.15
Altered heat pain thresholds and cerebral event-related potentials following painful CO2 laser stimulation in subjects with fibromyalgia syndrome. Pain (1994) 1.15
Procoagulant activity expression by macrophages from atheromatous vascular plaques. Atherosclerosis (1989) 1.15
Glomerular procoagulant activity in human proliferative glomerulonephritis. J Clin Invest (1988) 1.14
Lung function abnormalities and decline of spirometry in scleroderma: an overrated danger? Postgrad Med J (1991) 1.11
Continuation of long term treatment with hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis (1992) 1.09
Detection of intracellular lipocortin 1 in human leukocyte subsets. Clin Immunol Immunopathol (1995) 1.08
Diagnosis of Mycobacterium tuberculosis infection using ESAT-6 and intracellular cytokine cytometry. Clin Exp Immunol (2005) 1.07
Cellular immune mechanisms in human glomerulonephritis: the role of mononuclear leucocytes. Springer Semin Immunopathol (1982) 1.07
Macrophage-induced glomerular injury. Cell transfer studies in passive autologous antiglomerular basement membrane antibody-initiated experimental glomerulonephritis. Lab Invest (1984) 1.06
The participation of macrophages and monocytes in experimental immune complex glomerulonephritis. Clin Immunol Immunopathol (1980) 1.06
Antiinflammatory effect of lipocortin 1 in experimental arthritis. Inflammation (1997) 1.05
Life table analysis of 879 treatment episodes with slow acting antirheumatic drugs in community rheumatology practice. J Rheumatol (1992) 1.04
Glomerular interleukin 1 production is dependent on macrophage infiltration in anti-GBM glomerulonephritis. Kidney Int (1991) 1.04
Interleukin-8 production by macrophages from atheromatous plaques. Arterioscler Thromb Vasc Biol (1996) 1.04
Glomerular tissue factor expression in crescentic glomerulonephritis. Correlations between antigen, activity, and mRNA. Am J Pathol (1995) 1.02
Interleukin-4 deficiency enhances Th1 responses and crescentic glomerulonephritis in mice. Kidney Int (1998) 1.01
Repetitive strain syndrome: an Australian experience. J Rheumatol (1986) 1.01
IL-12 directs severe renal injury, crescent formation and Th1 responses in murine glomerulonephritis. Eur J Immunol (1999) 1.01
Popliteal cyst rupture in septic arthritis. Med J Aust (1982) 1.00
Anti-neutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritis. Clin Exp Immunol (1997) 1.00
Cell characteristics of cultured glomeruli from different animal species. Nephron (1978) 0.99
Methotrexate therapy in rheumatoid arthritis: a life table review of 587 patients treated in community practice. J Rheumatol (1993) 0.99
Interleukin-4 and interleukin-10 attenuate established crescentic glomerulonephritis in mice. Kidney Int (1997) 0.98
The participation of macrophages, glomerular procoagulant activity, and factor VIII in glomerular fibrin deposition. Studies on anti-GBM antibody-induced glomerulonephritis in rabbits. Am J Pathol (1986) 0.98
Hydroxyl radical mediation of immune renal injury by desferrioxamine. Kidney Int (1986) 0.97
Effect of cyclosporin A on antibody-induced experimental glomerulonephritis. Nephron (1985) 0.97
The effect of maintenance dialysis on lymphocyte function. I. Haemodialysis. Clin Exp Immunol (1978) 0.96
Lymphokine (MIF) production by glomerular T-lymphocytes in experimental glomerulonephritis. Kidney Int (1986) 0.96
Interleukin-10 inhibits macrophage-induced glomerular injury. J Am Soc Nephrol (2000) 0.96
Major histocompatibility complex class II expression by intrinsic renal cells is required for crescentic glomerulonephritis. J Exp Med (1998) 0.96
A comparison of fibrinolytic and defibrinating agents in established experimental glomerulonephritis. Br J Exp Pathol (1986) 0.93
Cyclosporine treatment reduces early atherosclerosis in the cholesterol-fed rabbit. Atherosclerosis (1995) 0.92
Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis. Clin Exp Immunol (2002) 0.92
Tissue culture of isolated glomeruli from patients with glomerulonephritis. Kidney Int (1980) 0.92
The painful swollen calf. A comparative evaluation of four investigative techniques. Med J Aust (1986) 0.92
Mycobacterial disease in the musculoskeletal system. Med J Aust (1987) 0.91
Pulmonary manifestations of the clinical syndrome of acute glomerulonephritis and lung hemorrhage. Am J Kidney Dis (1986) 0.91
Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives. Am J Hematol (1999) 0.91
IL-18 has IL-12-independent effects in delayed-type hypersensitivity: studies in cell-mediated crescentic glomerulonephritis. J Immunol (2000) 0.90
Crescentic glomerulonephritis--a manifestation of a nephritogenic Th1 response? Histol Histopathol (2000) 0.90
Alveolar macrophage procoagulant activity is increased in acute hyperoxic lung injury. Am J Pathol (1988) 0.90